Chelsea N Zimmerman Selected Research

Dihydro-beta-Erythroidine

1/2017

Evaluation of AZD1446 as a Therapeutic in DYT1 Dystonia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chelsea N Zimmerman Research Topics

Disease

2	Dystonia musculorum deformans type 1 01/2017 - 01/2017
2	Dystonia (Limb Dystonia) 01/2017 - 01/2017
1	Hyperkinesis 01/2017
1	Schizophrenia (Dementia Praecox) 01/2017
1	Basal Ganglia Diseases (Basal Ganglia Disease) 01/2017
1	Dyskinesias (Dyskinesia) 01/2017

Drug/Important Bio-Agent (IBA)

2	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2017 - 01/2017
2	Dopamine (Intropin)FDA LinkGeneric 01/2017 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 01/2017
2	Cholinergic Agents (Cholinergics)IBA 01/2017 - 01/2017
2	Cholinergic Antagonists (Anticholinergics)IBA 01/2017 - 01/2017
1	Levodopa (L Dopa)FDA LinkGeneric 01/2017
1	Nicotine FDA Link 01/2017
1	Muscarinic AntagonistsIBA 01/2017
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 01/2017
1	3- (5- chloro- 2- furoyl)- 3,7- diazabicyclo(3.3.0)octaneIBA 01/2017
1	ArrestinIBA 01/2017
1	Dihydro-beta-ErythroidineIBA 01/2017
1	Nicotinic AgonistsIBA 01/2017

Therapy/Procedure

1	Therapeutics 01/2017